AHIP Criticizes Avalere Report On Generic Drug Costs

An Avalere analysis that asserts generic drug costs are rising for seniors in Part D due to plans putting generics on higher-cost tiers is “mostly founded on general speculation versus reliable fact,” a spokesperson for America’s Health Insurance Plans alleges. The Avalere report says generic drug out-of-pocket costs are rising for seniors , despite the fact that generic prices remained stable. “However, the study itself does not analyze or reflect actual beneficiary utilization and does not include any analysis of...